Revenue YoY
+0.42%
Operating Income YoY
-29.42%
Net Income YoY
-7.20%
Net Margin Δ
-117 bps
Net income bridge for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: −$106.91M-7.20%
Profit bridge breakdown for Biogen (BIIB) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $1.48B | — |
| Revenue | $41.00M | +38.3% |
| Cost of Revenue | −$224.20M | -209.7% |
| Operating Expenses | −$459.80M | -430.1% |
| Other Income / Expense | $358.60M | +335.4% |
| Income Tax | $177.49M | +166.0% |
| Net Income | $1.37B | — |
- Prior Net Income$1.48B
- Revenue$41.00M
- Cost of Revenue−$224.20M
- Operating Expenses−$459.80M
- Other Income / Expense$358.60M
- Income Tax$177.49M
- Net Income$1.37B
Identity check: drivers reconcile to ΔNI within $0.00 ✓
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement